Fla. researchers develop personalized radiation model
August 23, 2019 -- A radiation therapy model that personalizes treatment based on patient genomics has been developed by a team from the Moffitt Cancer Center and Research Institute in Tampa, FL, according to a study published August 12 in EBioMedicine.
IBA posts revenue increase in 1st half of 2019
August 22, 2019 -- Proton therapy developer Ion Beam Applications (IBA) posted revenue growth in the first half of 2019, which it attributed to sales of its Proteus One proton therapy system and other accelerator systems.
ViewRay touts clinical trial on MRI-guided radiotherapy
August 19, 2019 -- Image-guided radiation therapy vendor ViewRay is highlighting a prospective clinical trial that confirmed the safety of using its MRIdian MRI-guided radiation therapy to treat prostate cancer.
Accuray posts higher sales in Q4
August 19, 2019 -- Radiation oncology firm Accuray reported financial results for its fiscal fourth quarter that showed revenue edging up while its net loss grew.
NRC proposes changes to rules on radiotracer patients
August 15, 2019 -- The U.S. Nuclear Regulatory Commission (NRC) is proposing several updates in its regulatory guide on how best to handle patients who receive radioactive materials as part of their imaging scans.  Discuss
Qfix, Mevion partner on proton therapy systems
August 5, 2019 -- Radiotherapy positioning technology developer Qfix said that it has validated a special version of its kVue One couch top for use with proton therapy systems from Mevion Medical Systems.
Varian posts 16% revenue gain in Q3
July 25, 2019 -- Radiation oncology firm Varian Medical Systems posted revenue gains in its third quarter and first nine months of fiscal 2019.
ASTRO names new officers to its board
July 24, 2019 -- The American Society for Radiation Oncology (ASTRO) has elected four new officers to its board of directors.
Mevion, RaySearch extend partnership
July 24, 2019 -- Mevion Medical Systems and radiation therapy software developer RaySearch have extended their collaboration on proton therapy products and technologies.
Accuray moves forward with China joint venture
July 23, 2019 -- Radiation oncology firm Accuray said that its joint venture with CNNC High Energy Equipment of Tianjin, China, has received the required licenses and permits to begin selling and installing Accuray's radiation therapy devices in China.
Special Feature
ASTRO: Prostate RT works better than expected in black men

Radiation therapy (RT) could be more effective in African-American men with prostate cancer than previously realized, according to data presented at the American Society for Radiation Oncology (ASTRO) annual meeting. Read more